Heteroaryl substituted benzoic acids as RORgammaT inhibitors and uses thereof
The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
10.03.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions. |
---|---|
Bibliography: | Application Number: US201615770257 |